102 related articles for article (PubMed ID: 12145060)
1. Intravenous verapamil blunts hyperdynamic responses during electroconvulsive therapy without altering seizure activity.
Wajima Z; Yoshikawa T; Ogura A; Imanaga K; Shiga T; Inoue T; Ogawa R
Anesth Analg; 2002 Aug; 95(2):400-2, table of contents. PubMed ID: 12145060
[TBL] [Abstract][Full Text] [Related]
2. The effects of intravenous lignocaine on haemodynamics and seizure duration during electroconvulsive therapy.
Wajima Z; Yoshikawa T; Ogura A; Shiga T; Inoue T; Ogawa R
Anaesth Intensive Care; 2002 Dec; 30(6):742-6. PubMed ID: 12500511
[TBL] [Abstract][Full Text] [Related]
3. The effects of diltiazem on hemodynamics and seizure duration during electroconvulsive therapy.
Wajima Z; Yoshikawa T; Ogura A; Imanaga K; Shiga T; Inoue T; Ogawa R
Anesth Analg; 2001 May; 92(5):1327-30. PubMed ID: 11323371
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine blunts acute hyperdynamic responses to electroconvulsive therapy without altering seizure duration.
Begec Z; Toprak HI; Demirbilek S; Erdil F; Onal D; Ersoy MO
Acta Anaesthesiol Scand; 2008 Feb; 52(2):302-6. PubMed ID: 17976228
[TBL] [Abstract][Full Text] [Related]
5. Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy.
Avramov MN; Stool LA; White PF; Husain MM
J Clin Anesth; 1998 Aug; 10(5):394-400. PubMed ID: 9702620
[TBL] [Abstract][Full Text] [Related]
6. Effects of remifentanil on convulsion duration and hemodynamic responses during electroconvulsive therapy: a double-blind, randomized clinical trial.
Nasseri K; Arasteh MT; Maroufi A; Shami S
J ECT; 2009 Sep; 25(3):170-3. PubMed ID: 19755938
[TBL] [Abstract][Full Text] [Related]
7. Landiolol attenuates acute hemodynamic responses but does not reduce seizure duration during maintenance electroconvulsive therapy.
Sakamoto A; Ogawa R; Suzuki H; Kimura M; Okubo Y; Fujiya T
Psychiatry Clin Neurosci; 2004 Dec; 58(6):630-5. PubMed ID: 15601388
[TBL] [Abstract][Full Text] [Related]
8. The use of nicardipine for electroconvulsive therapy: a dose-ranging study.
Zhang Y; White PF; Thornton L; Perdue L; Downing M
Anesth Analg; 2005 Feb; 100(2):378-381. PubMed ID: 15673861
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
[TBL] [Abstract][Full Text] [Related]
10. Topical verapamil and episcleral venous pressure.
Abreu MM; Kim YY; Shin DH; Netland PA
Ophthalmology; 1998 Dec; 105(12):2251-5. PubMed ID: 9855155
[TBL] [Abstract][Full Text] [Related]
11. Acute hemodynamic responses to electroconvulsive therapy are not related to the duration of seizure activity.
Fu W; Stool LA; White PF; Husain MM
J Clin Anesth; 1997 Dec; 9(8):653-7. PubMed ID: 9438894
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion: clinical experience in the intensive care unit.
De Cicco M; Macor F; Robieux I; Zanette G; Fantin D; Fabiani F; Nicolosi G; Fracasso A; Toffoli G; Santantonio C; Lestuzzi C; Matovic M; Boiocchi M
Crit Care Med; 1999 Feb; 27(2):332-9. PubMed ID: 10075058
[TBL] [Abstract][Full Text] [Related]
13. [The effect of verapamil on cardio- and hemodynamics in rats with various models of hypertension].
Spasov AA; Gurbanov KG; Seredintseva NV; Paperno AA
Eksp Klin Farmakol; 1997; 60(3):30-3. PubMed ID: 9324394
[TBL] [Abstract][Full Text] [Related]
14. Effects of four calcium channel blockers on central cardiovascular control.
Montastruc JL; Damase-Michel C; Dang-Tran L; Montastruc P
Arch Int Pharmacodyn Ther; 1989; 297():112-9. PubMed ID: 2730230
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of verapamil enantiomer combinations in conscious dogs.
Pagel PS; Hettrick DA; Lowe D; Gowrie PW; Kersten JR; Bosnjak ZJ; Warltier DC
Eur J Pharmacol; 1998 May; 348(2-3):213-21. PubMed ID: 9652336
[TBL] [Abstract][Full Text] [Related]
16. Effects of KT-362, a new calcium release blocker, on vascular selectivity and hemodynamic actions in anesthetized dogs.
Wakabayashi S; Mochizuki S; Tomiyama A; Shibata S
Jpn J Pharmacol; 1990 Sep; 54(1):23-32. PubMed ID: 2273645
[TBL] [Abstract][Full Text] [Related]
17. Slow infusion of calcium channel blockers compared with intravenous adenosine in the emergency treatment of supraventricular tachycardia.
Lim SH; Anantharaman V; Teo WS; Chan YH
Resuscitation; 2009 May; 80(5):523-8. PubMed ID: 19261367
[TBL] [Abstract][Full Text] [Related]
18. The role of calcium channel blockers in the treatment of hypertension.
Halperin AK; Cubeddu LX
Am Heart J; 1986 Feb; 111(2):363-82. PubMed ID: 3511651
[No Abstract] [Full Text] [Related]
19. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study.
Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Fluckiger L; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; van Roon AM; Smit AJ
Am J Hypertens; 2001 Nov; 14(11 Pt 1):1083-9. PubMed ID: 11724204
[TBL] [Abstract][Full Text] [Related]
20. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Keuskamp J; Murali R; Chao KH
J Neurosurg; 2008 Mar; 108(3):458-63. PubMed ID: 18312091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
